Merck is undervalued with strong growth, profitability, and credit strength despite CDMO challenges, offering compelling ...

Merck KGaA (MKKGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Merck Foundation Together with African and Asian First Ladies Mark 'World Assisted Reproductive Technology Day' 2025 ...

Kai Beckmann, CEO of Electronics at Merck KGaA, discusses Europe's competitiveness in AI development. Trump admin proposes ...

Merck Foundation has produced nearly 30 original songs that speak to infertility, female empowerment, and reproductive rights ...

Merck Foundation has pioneered a new era in fertility care across Africa and Asia by training local embryologists and ...

The Merck Foundation Health Media Training is a part of ‘Merck Foundation More than a Mother’ Community Awareness Program. Since 2017, Merck Foundation has provided their Health Media Training for ...

Merck KGaA (NYSE:MRK) said that the European Commission approved Ezmekly for treating symptomatic, inoperable plexiform ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Merck KGaA has synthesized transcriptional coactivator YAP1/transcriptional enhancer factor (TEAD) and/or TAZ/TEAD interaction inhibitors reported to be useful for the treatment of cancer.

Merck will reduce its workforce by approximately 6,000 employees in “some areas of our global workforce,” the New Jersey ...